Asklepios Klinik St George — Clinical Trial Site

28 Registered trials

10 Currently recruiting

Organisation

Asklepios Klinik St George

Location

Hamburg, Germany

Identifier

ORG-100028805

Address

Lohmuehlenstrasse 5, St. Georg, 20099, Germany

Departments

#3002: Herzzentrum St. Georg Hamburg Klinik für Kardiologie und Internistische Intensivmedizin
1202: Innere Medizin, Gastroenterologie
Abt. für Hämatologie, Onkologie und Stammzelltransplantation
Abteilung fuer Haematologie, Onkologie und Stammzelltransplantation
Asklepios proresearch
Asklepios Tumorzentrum Hamburg
Department Hematology Oncology and Stem cell research
Department Hematology Oncology and Stem cell research
Department of Hematology, Oncology and Stem Cell Research
Haematologische Abteilung
Hämatologie, Onkologie und Stammzelltransplantation
Hämatologie, Onkologie, Stammzelltransplantation
Hematology
Hematology, Oncology and Stem Cell research
Innere Medizin und Gastroenterologie
Internal Medicine and Gastroenterology
Kardiologie
Kardiologie und Internistische Intensivmedizin
Medizinische Versorgungszentrum Prof. Mathey, Prof. Schofer GmbH
N/A
Onkologie

Clinical trials at this site (28)

Search interface

A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta… Pending

2025-523869-22-00 advanced or metastatic extrapulmonary neuroendocrine ca 5
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
EASE SBS 5 (Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS) Recruiting

2024-512486-14-00 Short Bowel Syndrome 5 2026-01-22
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A Randomized, Placebo‐Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Di… Recruiting

2023-507518-28-00 Acute myeloid leukemia 5 2022-09-13
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting

2025-520518-79-00 Atrial Fibrillation 4 2026-01-06
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen Recruiting

2024-519875-24-00 Carcinoid syndrome 5 2025-09-26
A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study of 2 Doses of Crofelemer for the Treatment of adult patients with Short Bowel … Recruiting

2024-511994-31-00 Short Bowel Syndrome and Intestinal Failure (SBS-IF) wi 4 2025-03-10
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::AB 4 2023-07-13
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal Failure Recruiting

2024-515160-32-00 Short Bowel Syndrome-associated Intestinal Failure (SBS 4 2022-02-02
A trial to assess the long-term safety and effectiveness of glepaglutide in patients with short bowel syndrome who have been previously trea… Ended

2025-520775-81-00 Short Bowel Syndrome 5 2025-12-23
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection Ended

2022-501901-10-00 Chronic Hepatitis D Infection 6 2023-02-06
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
Long-term safety of apraglutide in short bowel syndrome Ended

2023-510389-28-00 short bowel syndrome 5 2021-06-14
Post-operative adjuvant treatment for HPV-positive tumours Ended

2024-516673-68-00 Human papillomavirus (HPV)-positive oropharyngeal cance 5 2020-10-27
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) inductio… Ended

2024-513464-26-00 Multiple Myeloma 5 2018-10-18
Axicabtagene Ciloleucel CAR T-Cells in Patients with relapsed or refractory primary mediastinal B-Cell Lymphoma Ended

2024-510972-19-00 Primary mediastinal large B-cell lymphoma (PMBCL) 4 2025-03-13
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma af… Ended

2024-510590-14-00 multiple myeloma 5 2023-03-03